Medistim Asa Stock Short Ratio
| MEDI Stock | NOK 147.00 5.00 3.29% |
Medistim ASA fundamentals help investors to digest information that contributes to Medistim ASA's financial success or failures. It also enables traders to predict the movement of Medistim Stock. The fundamental analysis module provides a way to measure Medistim ASA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medistim ASA stock.
Medistim |
Medistim ASA Company Short Ratio Analysis
Medistim ASA's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, Medistim ASA has a Short Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The short ratio for all Norway stocks is 100.0% higher than that of the company.
Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Medistim Fundamentals
| Return On Equity | 0.31 | |||
| Return On Asset | 0.2 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 4.12 B | |||
| Shares Outstanding | 18.26 M | |||
| Shares Owned By Insiders | 14.97 % | |||
| Shares Owned By Institutions | 73.95 % | |||
| Price To Earning | 36.32 X | |||
| Price To Book | 12.24 X | |||
| Price To Sales | 9.15 X | |||
| Revenue | 417.82 M | |||
| Gross Profit | 320.7 M | |||
| EBITDA | 137.68 M | |||
| Net Income | 90.9 M | |||
| Cash And Equivalents | 129.49 M | |||
| Cash Per Share | 2.99 X | |||
| Total Debt | 17.08 M | |||
| Debt To Equity | 3.40 % | |||
| Current Ratio | 3.68 X | |||
| Book Value Per Share | 18.94 X | |||
| Cash Flow From Operations | 128.14 M | |||
| Earnings Per Share | 5.34 X | |||
| Target Price | 290.0 | |||
| Number Of Employees | 116 | |||
| Beta | 0.75 | |||
| Market Capitalization | 4.24 B | |||
| Total Asset | 403.24 M | |||
| Working Capital | 93 M | |||
| Current Asset | 136 M | |||
| Current Liabilities | 43 M | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 2.62 % | |||
| Net Asset | 403.24 M | |||
| Last Dividend Paid | 3.75 |
About Medistim ASA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medistim ASA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medistim ASA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medistim ASA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Medistim Stock
Medistim ASA financial ratios help investors to determine whether Medistim Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medistim with respect to the benefits of owning Medistim ASA security.